Powered by

Allergan purchases aesthetic medicine company Kythera Biopharmaceuticals for $2.1B

Jun 17, 2015 - The Deal Pipeline

Dublin, Ireland-based Allergan plc (AGN) announced on Wednesday that it would acquire aesthetic medicine company Kythera Biopharmaceuticals (KYTH) for $2.1 billion.

Under the terms of the agreement Allergan will purchase the company in a cash and equity deal, paying out $75 per Kythera share. Allergan will pay 80 percent in cash and 20 percent in new shares to be issued to Kythera shareholders. Shares of  Westlake Village, Ca.-based Kythera closed on Tuesday at $60.72, giving the compan...